OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 61 filers reported holding OVID THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,175 | +17.0% | 306 | 0.0% | 0.00% | – |
| Q2 2023 | $1,004 | +17.6% | 306 | -7.6% | 0.00% | – |
| Q1 2023 | $854 | -14.6% | 331 | 0.0% | 0.00% | – |
| Q4 2022 | $1,000 | 0.0% | 331 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 331 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 331 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 331 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 331 | -23.2% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 431 | +6.2% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 406 | -19.8% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 506 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -66.7% | 506 | -4.7% | 0.00% | – |
| Q3 2020 | $3,000 | -50.0% | 531 | -36.1% | 0.00% | – |
| Q2 2020 | $6,000 | – | 831 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 1,319,679 | $4,329 | 18.57% |
| Madison Avenue Partners, LP | 3,307,605 | $10,848,943 | 2.37% |
| CHI Advisors LLC | 864,822 | $2,836,616 | 0.86% |
| Rubric Capital Management LP | 5,445,910 | $17,862,585 | 0.76% |
| BVF INC/IL | 6,851,051 | $22,471,447 | 0.63% |
| EcoR1 Capital, LLC | 6,117,400 | $20,065,072 | 0.49% |
| Artal Group S.A. | 2,500,000 | $8,200 | 0.25% |
| Tejara Capital Ltd | 112,591 | $369,298 | 0.18% |
| DCF Advisers, LLC | 64,764 | $212,426 | 0.11% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 801,152 | $2,627,779 | 0.06% |